Luca Toti

Prof. Luca Toti

Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Journal of Hepatology
Verified
Journal Article
Closed access
GTGiuseppe Tisone
Giuseppe Tisone
GOGiuseppe Orlando
Giuseppe Orlando
ACAndrea Cardillo
Andrea Cardillo
GPGiampiero Palmieri
Giampiero Palmieri
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
MAMario Angelico
Mario Angelico

28 May 2011 in Transplantation Proceedings
Verified
Journal Article
Closed access
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
Roberta AngelicoRoberta Angelico
Roberta Angelico
Luca TotiLuca Toti
Luca Toti
ACA. Cillis
A. Cillis
PCP. Ciano
P. Ciano
GTGiuseppe Tisone
Giuseppe Tisone

1 April 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
GTGiuseppe Tisone
Giuseppe Tisone
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
SZS Zazza
S Zazza
NCN De Liguori Carino
N De Liguori Carino
CCC Ciceroni
C Ciceroni
CCC.U Casciani
C.U Casciani

1 January 2015 in Surgery
Verified
Journal Article
Closed access
GOGiuseppe Orlando
Giuseppe Orlando
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
RSRoberto Sorge
Roberto Sorge
GIGiuseppe Iaria
Giuseppe Iaria
Roberta AngelicoRoberta Angelico
Roberta Angelico
JRJacopo Romagnoli
Jacopo Romagnoli

1 January 2009 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
ILIlaria Lenci
Ilaria Lenci
AAAce Alvior
Ace Alvior
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
Luca TotiLuca Toti
Luca Toti
JNJames Neuberger
James Neuberger
Richard SteedsRichard Steeds
Richard Steeds

23 February 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
Tommaso Maria ManziaTommaso Maria Manzia
Tommaso Maria Manzia
CGCarlo Gazia
Carlo Gazia
ILIlaria Lenci
Ilaria Lenci
Roberta AngelicoRoberta Angelico
Roberta Angelico
Luca TotiLuca Toti
Luca Toti
GTGiuseppe Tisone
Giuseppe Tisone
The coronavirus disease 2019 (COVID‐19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 currently affected more than 108 million people worldwide with a fatality rate of 2.2%. Herein, we report the first case of liver transplantation (LT) performed with a liver procured from a SARS‐CoV‐2 positive donor. The recipient was a 35‐year‐old SARS‐CoV‐2 positive female patient affected by severe end‐stage HBV‐HDV‐related liver disease (model of end‐stage liver disease = 32) who had neutralizing SARS‐CoV‐2 antibodies (titers 1:320) at time of LT. The LT was successful, and the graft is functioning two months after surgery. The recipient cleared the SARS‐CoV‐2 infection 1 month after LT. The current case shows that the prompt use of SARS‐CoV‐2 infected liver donors offers an invaluable life‐saving opportunity for SARS‐CoV‐2 positive wait‐listed patients who developed neutralizing SARS‐CoV‐2 antibodies.